Histologic Subtyping of Gastric Intestinal Metaplasia: Overview and Considerations for Clinical Practice
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Gastric cancer remains the third leading cause of cancer-related mortality and the fifth most common cancer worldwide, responsible for an estimated 1 million new cases and more than 780,000 deaths in 2018 alone.1 Gastric adenocarcinoma is the most common form of gastric cancer, of which there are 2 histologic subtypes: intestinal-type and diffuse-type. Intestinaltype gastric adenocarcinoma is the final stage of the chronic inflammation to dysplasiacarcinoma sequence, known as the Correa cascade, with Helicobacter pylori-induced gastritis as the most common initial trigger.2–4 Atrophic gastritis and gastric intestinal metaplasia (GIM) are established pre-neoplastic lesions for intestinal-type gastric adenocarcinoma.2,5 As reported in the American Gastroenterological Association Technical Review informing the guidelines for GIM surveillance, the pooled incidence rate for the progression of GIM in the absence of dysplasia to gastric cancer was 12.4 (95% confidence interval, 10.7-14.3) per 10,000 person-years; this was based on 10 cohort studies that included nearly 26,000 patients with non-dysplastic GIM.6,7 Currently, we are neither able to predict who will develop pre-neoplasia nor who will subsequently have neoplastic progression. As such, focused efforts on identifying and further defining predictive determinants are needed immediately.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Capelle, L. G., de Vries, A. C., Haringsma, J., Ter Borg, F., de Vries, R. A., Bruno, M. J., van Dekken, H., Meijer, J., van Grieken, N. C. T., & Kuipers, E. J. (2010) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2009.12.029 · Cited by 608
Pathology of gastric intestinal metaplasia: clinical implications
Correa, P., Piazuelo, B. M., & Wilson, K. T. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.728 · Cited by 405
AGA clinical practice guidelines on management of gastric intestinal metaplasia
Gupta, S., Li, D., El Serag, H. B., Davitkov, P., Altayar, O., Sultan, S., Falck-Ytter, Y., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.003 · Cited by 320
The role of endoscopy in the management of premalignant and malignant conditions of the stomach
Evans, J. A., Chandrasekhara, V., Chathadi, K. V., Decker, G. A., Early, D. S., Fisher, D. A., Foley, K., Hwang, J. H., Jue, T. L., Lightdale, J. R., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2015.03.1967 · Cited by 304
AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes
Gawron, A. J., Shah, S. C., Altayar, O., Davitkov, P., Morgan, D., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.001 · Cited by 175
Self-citationAGA technical review on gastric intestinal metaplasia-epidemiology and risk factors
Altayar, O., Davitkov, P., Shah, S. C., Gawron, A. J., Morgan, D. R., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.002 · Cited by 135
Self-citation
Cited by
AGA technical review on gastric intestinal metaplasia-natural history and clinical outcomes
Gawron, A. J., Shah, S. C., Altayar, O., Davitkov, P., Morgan, D., Turner, K., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.001 · Cited by 175
Self-citationPiazuelo, M. B., Bravo, L. E., Mera, R. M., Camargo, M. C., Bravo, J. C., Delgado, A. G., Washington, M. K., Rosero, A., Garcia, L. S., Realpe, J. L., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2020.11.017 · Cited by 148
Self-citationTargeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Metadata
- Authors
- Shah, S. C., Gawron, A. J., Mustafa, R. A., & Piazuelo, M. B.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 158
- Issue
- 3
- Pages
- 745-750
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2992576621
- Cited by
- 112
- References
- 7
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.